logo
  

Amended: France's BIOCORP, Merck Sign Partnership To Develop Specific Version Of Mallya Device

French medical devices maker BIOCORP announced Thursday an agreement with Merck (MKGAY.PK), a science and technology company for the development and supply of a specific version of Mallya device to monitor treatment adherence in the field of Human Growth Hormone or HGH.

Following the development of the device, the companies plan to market the product on a global scale.

Following the completion of different milestones, Merck will pay around 3 million euros for the development of the specific solution. After the development phase, BIOCORP will manufacture the commercial units on behalf of Merck, which will generate additional revenues.

Mallya, manufactured in Clermont-Ferrand in France, is a Bluetooth enabled clip-on device for pen injectors. It collects dose and time of each injection and transfers information in real time to a companion software.

The device will help patients, including children and teenagers, automatically keep track of their HGH daily injection and monitor adherence with their treatment plan.

The company noted that Mallya is the first in its category to receive the CE-mark (medical device). Commercial versions for insulin pen injectors are already available and distributed in Europe and other geographies.

[corrects and replaces Merck & Co Inc. (MRK) with Merck (MKGAY.PK)]

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Rancho Cordova, California-based E-filliate Inc. is recalling about 301,800 units of DEWALT wireless earphones citing burn and fire risks, the U.S. Consumer Product Safety Commission said. The recall involves DEWALT Jobsite Pro Wireless Earphones, which have a black and yellow neckband with wired earbuds. According to the agency, the wireless earphones can overheat while charging or in use. The five-day holiday shopping period from Thanksgiving Day through Cyber Monday saw about 180 million Americans making in-store and online purchases, according to the National Retail Federation's Annual Thanksgiving Weekend Consumer Survey, conducted by Prosper Insights & Analytics. The shoppers spent an average of $301.27 on holiday-related purchases such as gifts, décor, apparel and toys. Biopharmaceutical company Immunome, Inc. (IMNM) announced Wednesday that it has conducted an assessment of the reported mutations in the new SARS-CoV-2 variant, Omicron (B.1.1.529). Based upon structural mapping of those mutations and activity against previous and current CDC variants of concern,...
Follow RTT